ING2 in cell cycle regulation

Cell Cycle

Volumn 9, Issue 19, 2010, Pages 3842-3847

  Li, Gang ^a   Piche, Brad ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DOXORUBICIN; GROWTH INHIBITOR; HISTONE DEACETYLASE 1; INHIBITOR OF GROWTH 2; P21 ACTIVATED KINASE; PROTEIN P53; UNCLASSIFIED DRUG;

CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIVISION; CELL GROWTH; CHROMATIN; COLORECTAL CARCINOMA; DRUG SENSITIVITY; FIBROBLAST; GENE ACTIVATION; GENE SILENCING; HUMAN; LUNG NON SMALL CELL CANCER; MELANOMA; NOTE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 77958456565     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.19.13382     Document Type: Note

References (9)

1. Campos EI, et al. Cell Mol Life Sci 2004; 61:2597-613.
2. Garkavtsev I, et al. Nature 1998; 391:295-8.
3. Nagashima M, et al. Proc Natl Acad Sci USA 2001; 98:9671-6.
4. Nagashima M, et al. Oncogene 2003; 22:343-50.
5. Shiseki M, et al. Cancer Res 2003; 63:2373-8.
6. Larrieu D, et al. Cell Cycle 2010; 9:2984-90.
7. Lu F, et al. Brit J Cancer 2006; 95:80-6.
8. Ythier D, et al. Lung Cancer 2010; 69:180-6.
9. Shi X, et al. Nature 2006; 442:96-9.